Kaye Mark 4
4 · Elevance Health, Inc. · Filed Oct 4, 2023
Insider Transaction Report
Form 4
Kaye Mark
EVP & CFO
Transactions
- Award
Common Stock
2023-10-02+2,102→ 20,276 total - Award
Common Stock
2023-10-02+18,174→ 18,174 total - Award
Employee Stock Option (Right to Buy)
2023-10-02+8,076→ 8,076 totalExercise: $440.19Exp: 2033-10-02→ Common Stock (8,076 underlying)
Footnotes (3)
- [F1]Represents restricted share units. Restrictions lapse as follows: 6,058 shares each on 10/2/2024, 10/2/2025 and 10/2/2026.
- [F2]Represents restricted share units. Restrictions lapse as follows: 700 shares on 10/2/2024 and 701 shares each on 10/2/2025 and 10/2/2026.
- [F3]The option represents a right to purchase a total of 8,076 shares, and is exercisable in three annual installments of 2,692 shares each, beginning on 10/2/2024, which is the one-year anniversary of the option grant date.